Viridesco’s Golden THC/CBD 4:1 Oil gives yet another twist to the range of options available to patients looking to stay somewhat grounded, but still eager to experience substantial euphoric, mood-elevating effects, making it a perfect choice for anyone with chronic depression. With a 60% load of THC that’s four times its amount of CBD, this powerful extract is ideal for therapeutic use, but would also fit the lifestyle of an advanced recreational user. Among the multiple benefits of a balanced hybrid oil are its relaxing, pain relieving, and anti-inflammatory effects, which are also echoed in the CBDs. Cannabidiol is also recommended as an immunostimulant to those with compromised immune systems, a blood sugar-reducer for diabetics, a bone-growth stimulant for those with osteoporosis, a vasorelaxant for those with circulatory problems and hypertension, and as a powerful neuroprotectant for patients with a wide range of degenerative conditions, including Multiple Sclerosis, Alzheimer’s and Parkinson’s Disease. One 2mL syringe contains 1200mg of THC and 310mg of CBD in a top quality golden oil blend concentrated for maximum efficiency, even in miniscule doses.
This full-plant extract also features several other cannabinoids whose potential benefits are still being discovered including Cannabinol, the most sedative of the plant’s non-psychoactive compounds, which has shown great promise in stimulating appetite and treating anxiety, and Cannabigerol, which has demonstrated success as an anti-bacterial, anti-inflammatory, vasodilator and neuroprotectant, and has also been helpful in reducing intraocular pressure in glaucoma patients. All Viridesco oils feature a patented delivery system supplied with instructions that make it incredibly easy for caregivers and patients alike to administer precise doses in a clean and user-friendly way, and the product itself can be incorporated into edibles, and used topically and sublingually, as well as smoked, dabbed and vaped. Keep this product well out of reach of children and pets.